Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with an annual incidence
of~ 1 case per million population. Differentiating between ACC and benign adrenocortical …

Methods A working group established by ESES reviewed the current guidelines and
undertook a literature search of the PubMed database focused on several clinical questions …

Adrenocortical carcinoma (ACC) is a rare cancer with high recurrence rates and
heterogeneous clinical behavior. The role of adjuvant therapy remains unclear because of …

Background Hepatic resection (HR) is effective for colorectal or neuroendocrine liver
metastases. However, the role of HR for non-colorectal non-neuroendocrine liver …

Adrenocortical carcinoma (ACC) is a rare malignancy with an overall unfavorable prognosis.
Clinicians treating patients with ACC have noted accelerated growth in metastatic liver …

A 57-year-old woman was diagnosed with adrenocortical carcinoma. Following the
adrenalectomy, she underwent adjuvant radiation and mitotane therapy; however, liver …

Methods After discussion of limited available systemic therapy options, informed consent
was obtained. HAI pumps (HAIPs) were implanted in standard surgical fashion, 4 with …

Background Metastatic ACC is aggressive with few effective treatment options. It is unclear if
surgery after chemotherapy impacts survival in recurrent/metastatic (R/M) ACC. Moreover …

Abstract Background and Objectives Chemotherapeutic options for patients with
recurrent/metastatic adrenocortical carcinoma (ACC) are limited, leading to consideration for …

Background: Adrenocortical carcinoma (ACC) is a rare malignant tumor of adrenocortical
origin, often with an unfavorable survival. The estimated incidence is 0.7 to 2 per million per …